Prospera Financial Services’s Edwards Lifesciences EW Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-2,704
| Closed | -$200K | – | 1187 |
|
|
2024
Q4 | $200K | Buy |
+2,704
| New | +$200K | ﹤0.01% | 1086 |
|
|
2024
Q3 | – | Sell |
-3,072
| Closed | -$284K | – | 1140 |
|
|
2024
Q2 | $284K | Buy |
3,072
+158
| +5% | +$14.6K | 0.01% | 943 |
|
|
2024
Q1 | $278K | Buy |
+2,914
| New | +$278K | 0.01% | 928 |
|
|
2023
Q3 | – | Sell |
-22,070
| Closed | -$2.08M | – | 1025 |
|
|
2023
Q2 | $2.08M | Sell |
22,070
-5,333
| -19% | -$503K | 0.08% | 260 |
|
|
2023
Q1 | $2.27M | Sell |
27,403
-1,081
| -4% | -$89.4K | 0.09% | 256 |
|
|
2022
Q4 | $2.13M | Buy |
28,484
+1,315
| +5% | +$98.1K | 0.11% | 221 |
|
|
2022
Q3 | $2.25M | Buy |
27,169
+823
| +3% | +$68K | 0.12% | 215 |
|
|
2022
Q2 | $2.51M | Sell |
26,346
-977
| -4% | -$92.9K | 0.13% | 200 |
|
|
2022
Q1 | $3.22M | Buy |
27,323
+1,442
| +6% | +$170K | 0.13% | 183 |
|
|
2021
Q4 | $3.35M | Buy |
25,881
+3,170
| +14% | +$411K | 0.14% | 169 |
|
|
2021
Q3 | $2.57M | Buy |
22,711
+3,702
| +19% | +$419K | 0.13% | 193 |
|
|
2021
Q2 | $1.97M | Buy |
19,009
+286
| +2% | +$29.6K | 0.1% | 245 |
|
|
2021
Q1 | $1.57M | Buy |
18,723
+16,504
| +744% | +$1.38M | 0.09% | 256 |
|
|
2020
Q4 | $202K | Buy |
2,219
+1,100
| +98% | +$100K | 0.01% | 642 |
|
|
2020
Q3 | $89K | Buy |
+1,119
| New | +$89K | 0.03% | 436 |
|
|
2020
Q1 | – | Sell |
-2,616
| Closed | -$203K | – | 547 |
|
|
2019
Q4 | $203K | Buy |
+2,616
| New | +$203K | 0.02% | 565 |
|